Healthcare Developments In Digital Biomanufacturing Market – Growth Opportunities, Analysis, Forecast, Global, 2022

Digital Technologies Driving Transformational Growth Across The Biomanufacturing Value Chain,Digital Biomanufacturing Market,Digital Twins,Biomanufacturing

INDUSTRY
Healthcare

RELEASE DATE
03-Nov-2022
REGION
Global
DELIVERABLE TYPE
Technology Research

RESEARCH CODE
DA70-01-00-00-00
SKU
HC03598-GL-TR_27043
Yes
SHARE

Developments in Digital Biomanufacturing: Technology Growth Opportunities
Published on: 03-Nov-2022 | SKU: HC03598-GL-TR_27043

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

Digitalization of the entire value chain will drive next-generation biomanufacturing. The industry is all set to move away from the traditional pen-and-paper-based process to a more advanced, digitized, track-and-trace process that is aligned toward Industry 4.0. Digital tools applied across processes, monitoring, analytics, and operations have accelerated biomanufacturing with a data-driven approach. Digital biomanufacturing can streamline processes and assist with optimal use of resources.
Scalability and reproducibility are some of the crucial challenges in biomanufacturing, especially in the production of biologics, and cell and gene therapies, or viral vector manufacturing. Digitalization is enabling a sustainable, effective, cost-efficient, time-efficient, and error-free system for biomanufacturing.
IoT, automation/robotics, AI/machine learning, Digital Twins, and Blockchain have been deployed in various digital biomanufacturing processes, thereby ensuring a seamless and uninterrupted workflow. Digitalization enables the best control and optimization of starting materials; in upstream processes, it helps with cell culture and media optimization; for downstream processes, it helps select the best strategy for purification and impurity removal. Digital tools are also making best use of the historical biomanufacturing data to improve/optimize processes. Advanced sensors and cutting-edge software collect real-time data, which offers a complete picture of the bioreactor’s condition.
Advanced analytics helps users understand variations in data and predict the most suitable conditions for biomanufacturing of therapeutics. Digital tools and powerful software platforms empower scientists and engineers and help them offer better-quality, sustainable products to patients faster and at a lower cost.
The report analyzes the progress that the biomanufacturing industry has made in terms of digitalization and how the industry embraces technological advancement to lower biomanufacturing footprint and overcome the limitations of traditional methods.

Why Is It Increasingly Difficult to Grow?The Strategic Imperative 8™: Factors Creating Pressure on Digital Biomanufacturing Growth

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the Digital Biomanufacturing Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Research Methodology

Scope of Analysis

Segmentation

Growth Drivers

Growth Restraints

Benefits of Deploying Digital Biomanufacturing

Shift Toward a Full- Fledged Digitally Equipped Biomanufacturing Unit

Technology Convergence for Seamless Digital Biomanufacturing

Digitalization Increases Bioproduct Quality and Quantity

Application of Digital Biomanufacturing in Developing Therapeutics

Blockchain

AI/ML

Digital Twin

Automation & Robotics

IoT and Cloud

Data-driven Process Control and Optimization

Wide Adoption of Cell Culture Automation and Optimization in Upstream Process

Shift Toward Continuous Biomanufacturing for Downstream Processes

Industry Stakeholders Optimizing Upstream and Downstream Processes for a Smooth Transformation

Advanced Analytics for Biomanufacturing Data

Advanced Analytical System to Monitor Biomanufacturing

Advancements in Digital Analytical Tools for Real-Time Product Quality Check

New Approaches in Advanced Process Analytics

Predictive Approaches to Lead the Way Forward for Biomanufacturing

Digital Solution to Enable Efficient Factory Outcomes and Operational Challenges

Transformation to a Full-Fledged Digital Factory Operation Systems

Companies Improving the Entire Manufacturing Operations Digitally

Collaboration between CDMOs and Biopharmas to Increase Digitization of Biomanufacturing

Digital Solution to Improve Supply Chain

Digital Supply Chain Increases Transparency and Interaction

Blockchain Creating Safe and Well-covered Network for Supply Chain

The Path Ahead

Encouraging Funding Activities for the Adoption of Digital Biomanufacturing

Collaborations for Implementation of Digital Biomanufacturing

Collaborations for Implementation of Digital Biomanufacturing (continued)

Company Categorization Based on Digital Biomanufacturing Capabilities

Key Takeaways

Growth Opportunity 1: Adoption of Digital Twins

Growth Opportunity 1: Adoption of Digital Twins (continued)

Growth Opportunity 2: Incorporation of Predictive Analytics

Growth Opportunity 2: Incorporation of Predictive Analytics (continued)

Growth Opportunity 3: Targeted Acquisitions

Growth Opportunity 3: Targeted Acquisitions of Digital Technology Developers by CDMOs (continued)

Your Next Steps

Why Frost, Why Now?

Legal Disclaimer


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

15 Sep 2026   |   Global   |   Market Research

Vendor Profiles: Advanced Wound Care Management Market, Global, 2025

The wound care market is being transformed by advanced technologies and evolving care models that focus on improving patient outcomes and reducing healthcare costs. Innovations such as smart sensor-embedded dressings, artificial intelligence (AI)-based wound imaging systems, enhanced negative pressu...

11 Sep 2026   |   Global   |   Frost Radar

Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2026

Pharmaceutical commercialization is a multidimensional concept in the successful launch and distribution of a drug. The process includes the development of a pricing strategy that reflects the drug’s value, negotiation with payers to ensure drug cost coverage, regulatory compliance, and the generati...

07 Sep 2026   |   Global   |   Technology Research

Synthetic Antibodies and AI-Optimized Immunotherapies

Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...

28 Aug 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Digital Solutions, and Medical Imaging Solutions

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, digital solutions, and medical imaging solutions.The issue features advanced medical devices such as active bioelectr...

27 Aug 2026   |   Global   |   Frost Radar

Frost Radar: AI-Powered Molecular Diagnostics, 2026

AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

Digitalization of the entire value chain will drive next-generation biomanufacturing. The industry is all set to move away from the traditional pen-and-paper-based process to a more advanced, digitized, track-and-trace process that is aligned toward Industry 4.0. Digital tools applied across processes, monitoring, analytics, and operations have accelerated biomanufacturing with a data-driven approach. Digital biomanufacturing can streamline processes and assist with optimal use of resources. Scalability and reproducibility are some of the crucial challenges in biomanufacturing, especially in the production of biologics, and cell and gene therapies, or viral vector manufacturing. Digitalization is enabling a sustainable, effective, cost-efficient, time-efficient, and error-free system for biomanufacturing. IoT, automation/robotics, AI/machine learning, Digital Twins, and Blockchain have been deployed in various digital biomanufacturing processes, thereby ensuring a seamless and uninterrupted workflow. Digitalization enables the best control and optimization of starting materials; in upstream processes, it helps with cell culture and media optimization; for downstream processes, it helps select the best strategy for purification and impurity removal. Digital tools are also making best use of the historical biomanufacturing data to improve/optimize processes. Advanced sensors and cutting-edge software collect real-time data, which offers a complete picture of the bioreactor’s condition. Advanced analytics helps users understand variations in data and predict the most suitable conditions for biomanufacturing of therapeutics. Digital tools and powerful software platforms empower scientists and engineers and help them offer better-quality, sustainable products to patients faster and at a lower cost. The report analyzes the progress that the biomanufacturing industry has made in terms of digitalization and how the industry embraces technological advancement to lower biomanufacturing footprint and overcome the limitations of traditional methods.
More Information
New Title Developments In Digital Biomanufacturing Market – Growth Opportunities, Analysis, Forecast, Global, 2022
New Subtitle Digital Technologies Driving Transformational Growth Across The Biomanufacturing Value Chain,Digital Biomanufacturing Market,Digital Twins,Biomanufacturing
Deliverable Type Technology Research
Author Neeraja Vettekudath
Industries Healthcare
No Index No
Is Prebook No
Podcast No
WIP Number DA70-01-00-00-00

Developments in Digital Biomanufacturing: Technology Growth Opportunities

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC03598-GL-TR_27043